Elevated serum estrogen has previously been demonstrated to stimulate the proliferation of human cholangiocarcinoma, which similarly expresses estrogen receptors in tumoral tissue (Mancino et al., 2009; Hunsawong et al., 2012; Petrick et al., 2020). This evidence concerns the gene ESR1 and cholangiocarcinoma.